keyword
MENU ▼
Read by QxMD icon Read
search

Botox pelvic floor

keyword
https://www.readbyqxmd.com/read/26516810/adherence-to-oral-therapy-for-urgency-urinary-incontinence-results-from-the-anticholinergic-versus-botox-comparison-abc-trial
#1
RANDOMIZED CONTROLLED TRIAL
Anthony G Visco, Linda Brubaker, J Eric Jelovsek, Tracey S Wilson, Peggy Norton, Halina M Zyczynski, Cathie Spino, Larry Sirls, John N Nguyen, David D Rahn, Susie F Meikle, Tracy L Nolen
OBJECTIVES: Medication adherence with urgency urinary incontinence (UUI) treatment is challenging and the best assessment methodology is uncertain. We sought to describe adherence with anticholinergic (AC) versus placebo (P) by comparing pill counts and MEMSCAP event data and to identify factors associated with adherence. METHODS: The randomized controlled AC versus Botox Comparison trial of women with moderate to severe idiopathic UUI included 126 participants initiating AC plus P bladder injection and 121 receiving P pills plus Botox injection...
January 2016: Female Pelvic Medicine & Reconstructive Surgery
https://www.readbyqxmd.com/read/25900057/botulinum-toxin-a-injections-into-pelvic-floor-muscles-under-electromyographic-guidance-for-women-with-refractory-high-tone-pelvic-floor-dysfunction-a-6-month-prospective-pilot-study
#2
Darlene Morrissey, Dominique El-Khawand, Natasha Ginzburg, Salim Wehbe, Peter O'Hare, Kristene Whitmore
OBJECTIVES: High-tone pelvic floor dysfunction (HTPFD) is a debilitating chronic pain disorder for many women with significant impact on their quality of life (QoL). Our objective was to determine the efficacy of electromyography-guided onabotulinumtoxinA (Botox; Allergan, Irvine, Calif) injections in treating patient's perception of pelvic pain and improving QoL measurement scores. METHODS: This is a prospective pilot open-label study of women with chronic pelvic pain and HTPFD who have failed conventional therapy between January 2011 and August 2013...
September 2015: Female Pelvic Medicine & Reconstructive Surgery
https://www.readbyqxmd.com/read/25181372/committee-opinion-onabotulinumtoxina-and-the-bladder
#3
(no author information available yet)
In January 2013, the US Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have been shown to significantly improve after onabotulinumtoxinA injections compared with no intervention, placebo, pharmacological treatments, and bladder instillation technique. Before considering medical or surgical treatment, all patients in whom overactive bladder is diagnosed should receive instruction in behavioral techniques (eg, bladder retraining drills and timed voids), fluid management, or pelvic muscle exercises with or without physical therapy...
September 2014: Female Pelvic Medicine & Reconstructive Surgery
https://www.readbyqxmd.com/read/25015301/management-of-refractory-oab-in-the-non-neurogenic-patient
#4
REVIEW
Bassem S Wadie
Overactive bladder (OAB) is one of the most common bothersome urological diseases. It also has a negative economic impact. Pathophysiology entails changes in neurogenic and myogenic factors, as well as urinary biomarkers such as nerve growth factor (NGF) and prostaglandins (PGs). With symptoms from OAB-Dry to OAB-Wet, the urodynamic pattern of OAB bladder is often characterized by idiopathic detrusor overactivity with lower threshold of sensation, diminished compliance and capacity. Treatment ranges from a combination of behavioral modifications (BM)/ pelvic floor muscle training (PFMT) to combinations of antimuscarinics, Botox injection, nerve stimulation and augmentation cystoplasty...
September 2014: Current Urology Reports
https://www.readbyqxmd.com/read/24848923/committee-opinion-no-604-onabotulinumtoxina-and-the-bladder
#5
(no author information available yet)
In January 2013, the U.S. Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have been shown to significantly improve after onabotulinumtoxinA injections compared with no intervention, placebo, pharmacological treatments, and bladder instillation technique. Before considering medical or surgical treatment, all patients in whom overactive bladder is diagnosed should receive instruction in behavioral techniques (eg, bladder retraining drills and timed voids), fluid management, or pelvic muscle exercises with or without physical therapy...
June 2014: Obstetrics and Gynecology
https://www.readbyqxmd.com/read/24486637/the-refractory-overactive-bladder-sacral-neuromodulation-vs-botulinum-toxin-assessment-rosetta-trial
#6
RANDOMIZED CONTROLLED TRIAL
Cindy L Amundsen, Holly E Richter, Shawn Menefee, Sandip Vasavada, David D Rahn, Kim Kenton, Heidi S Harvie, Dennis Wallace, Susie Meikle
We present the rationale for and design of a randomized, open-label, active-control trial comparing the effectiveness of 200 units of onabotulinum toxin A (Botox A®) versus sacral neuromodulation (InterStim®) therapy for refractory urgency urinary incontinence (UUI). The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment (ROSETTA) trial compares changes in urgency urinary incontinence episodes over 6 months, as well as other lower urinary tract symptoms, adverse events and cost effectiveness in women receiving these two therapies...
March 2014: Contemporary Clinical Trials
https://www.readbyqxmd.com/read/23982578/botulinum-toxin-type-a-botox-for-refractory-myofascial-pelvic-pain
#7
Amos Adelowo, Michele R Hacker, Alex Shapiro, Anna Merport Modest, Eman Elkadry
OBJECTIVE: To assess intralevator botulinum toxin type A (Botox) injections for refractory myofascial pelvic pain with short tight pelvic floor. METHODS: Retrospective cohort study of all women with intralevator Botox injection (100-300 Units) from 2005 through 2010 for refractory myofascial pelvic pain. Primary outcomes were self-reported pain on palpation and symptom improvement. Secondary outcomes included postinjection complications and a second injection. Pain was assessed during digital palpation of the pelvic floor muscles using a scale of 0 to 10, with 10 being the worst possible pain...
September 2013: Female Pelvic Medicine & Reconstructive Surgery
https://www.readbyqxmd.com/read/21675619/solitary-rectal-ulcer-syndrome-exploring-possible-management-options
#8
Turker Bulut, Emel Canbay, Sumer Yamaner, Mine Gulluoglu, Dursun Bugra
Solitary rectal ulcer syndrome (SRUS) is a rare condition with various causes that results in ischemic injury. The aim of this study was to assess the clinical findings, diagnosis, and outcomes of treatment in patients with SRUS. Between 1992 and 2006, a retrospective review was undertaken for all patients diagnosed with SRUS. Fifty-eight patients were diagnosed with SRUS. Among patients with paradoxic rectal spasm (PRS), lesions disappeared in 1 of 3 given applied biofeedback treatment, and in 2 of 4 injected with Botulinum toxin (Botox)...
January 2011: International Surgery
https://www.readbyqxmd.com/read/19566591/biofeedback-therapy-in-fecal-incontinence-and-constipation
#9
REVIEW
P Enck, I R Van der Voort, S Klosterhalfen
We examine the collected evidence for efficacy of biofeedback therapy (BFT) in incontinence and constipation by means of meta-analysis of randomized controlled trials. PubMed search was performed to identify treatment trials that match quality criteria (adequate control groups, randomization). They were entered into meta-analyses using fixed effect models and computing odds ratio (OR) and 95% confidence interval (CI) of treatment effects. For constipation, eight BFT trials were identified. In four trials, electromyographic (EMG) BFT was compared to non-BFT treatments (laxatives, placebo, sham training and botox injection), while in the remaining four studies EMG BFT was compared to other BFT (balloon pressure, verbal feedback) modes...
November 2009: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://www.readbyqxmd.com/read/19264089/gynecological-indications-for-the-use-of-botulinum-toxin-in-women-with-chronic-pelvic-pain
#10
REVIEW
Jason Abbott
Chronic pelvic pain in women is a common symptom with a wide variety of etiologies that demand accurate diagnosis and appropriate treatment if pain reduction is to be effected. Superficial conditions such as provoked vestibulodynia and problems affecting deeper structures such as pelvic floor muscle spasm are difficult to treat and can have significant impacts on quality of life for the sufferer. Apart from daily pain, symptoms such as painful intercourse (dyspareunia), painful bowel motions (dyschesia) and exacerbation of period pain (dysmenorrhea) are commonly reported by patients...
October 2009: Toxicon: Official Journal of the International Society on Toxinology
https://www.readbyqxmd.com/read/17351550/botox-injections-may-ease-tension-in-women-with-pelvic-muscle-spasms
#11
(no author information available yet)
No abstract text is available yet for this article.
April 2007: Mayo Clinic Women's Healthsource
https://www.readbyqxmd.com/read/16176887/overactive-bladder
#12
REVIEW
R M Freeman, O A Adekanmi
The overactive bladder is a common condition, which has significant effects on quality of life. The aetiology in most cases is unknown, and treatment outcomes have until recently been unsatisfactory. Management includes excluding pathology and implementing behavioural changes such as caffeine reduction, bladder and pelvic floor training, as well as antimuscarinic drug therapy. Compliance is often problematic, and this can be improved with some of the newer antimuscarinics with fewer side-effects, and a good therapist/patient relationship...
December 2005: Best Practice & Research. Clinical Obstetrics & Gynaecology
https://www.readbyqxmd.com/read/15663593/the-use-of-botulinum-toxin-type-a-botox-as-treatment-for-intractable-chronic-pelvic-pain-associated-with-spasm-of-the-levator-ani-muscles
#13
Angus J M Thomson, Sherin K Jarvis, Meegan Lenart, Jason A Abbott, Thierry G Vancaillie
No abstract text is available yet for this article.
February 2005: BJOG: An International Journal of Obstetrics and Gynaecology
https://www.readbyqxmd.com/read/15089868/pilot-study-of-botulinum-toxin-type-a-in-the-treatment-of-chronic-pelvic-pain-associated-with-spasm-of-the-levator-ani-muscles
#14
COMPARATIVE STUDY
Sherin K Jarvis, Jason A Abbott, Meegan B Lenart, Anneke Steensma, Thierry G Vancaillie
OBJECTIVE: To investigate whether botulinum toxin type A (BOTOX) injected into the levator ani muscles of women with objective pelvic floor muscle spasm decreases pain symptoms and improves quality of life. DESIGN: A prospective cohort study. SETTING: Outpatient clinic in a tertiary referral centre, Sydney, Australia. SAMPLE: Twelve women, aged 18-55 years, with objective pelvic floor muscle hypertonicity and a minimum 2-year history of chronic pelvic pain were recruited...
February 2004: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://www.readbyqxmd.com/read/11257648/botulinum-toxin-urethral-sphincter-injection-to-restore-bladder-emptying-in-men-and-women-with-voiding-dysfunction
#15
M W Phelan, M Franks, G T Somogyi, T Yokoyama, M O Fraser, J P Lavelle, N Yoshimura, M B Chancellor
PURPOSE: Botulinum toxin injection into the external urinary sphincter in spinal cord injured men with detrusor-sphincter dyssynergia has been reported. We expand the clinical use of botulinum toxin for a variety of bladder outlet obstructions and to decrease outlet resistance in patients with acontractile detrusor but who wish to void by the Valsalva maneuver. MATERIALS AND METHODS: Prospective treatment was performed for voiding dysfunction in 8 men and 13 women 34 to 74 years old...
April 2001: Journal of Urology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"